You just read:

Tissue Regeneration Therapeutics Engineered Mesenchymal Stromal Cells Advance Monoclonal Antibody Therapy

News provided by

Tissue Regeneration Therapeutics Inc. (TRT)

15 Aug, 2016, 12:40 ET